Cargando…

Exploratory MRI measures after intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis

BACKGROUND: Mesenchymal stem cells (MSC) have immunomodulatory and neuro-protective properties and are being studied for treatment of multiple sclerosis (MS). Tractography-based diffusion tensor imaging (DTI), cortical thickness (Cth) and T2 lesion volume (T2LV) can provide insight into treatment ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Jenny, Offerman, Erik, Lin, Jian, Fisher, Elizabeth, Planchon, Sarah M, Sakaie, Ken, Lowe, Mark, Nakamura, Kunio, Cohen, Jeffrey A, Ontaneda, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572894/ https://www.ncbi.nlm.nih.gov/pubmed/31236284 http://dx.doi.org/10.1177/2055217319856035

Ejemplares similares

Serum neurofilament light chain concentration in a phase 1/2 trial of autologous mesenchymal stem cell transplantation
por: Baldassari, Laura E, et al.
Publicado: (2019)

Evaluation of a connectivity-based imaging metric that reflects functional decline in Multiple Sclerosis
por: Koenig, Katherine A., et al.
Publicado: (2021)

Automatic segmentation of gadolinium-enhancing lesions in multiple sclerosis using deep learning from clinical MRI
por: Gaj, Sibaji, et al.
Publicado: (2021)

Influence of equipment changes on MRI measures of brain atrophy and brain microstructure in a placebo-controlled trial of ibudilast in progressive multiple sclerosis
por: Sakaie, Ken, et al.
Publicado: (2021)

Gadolinium‐based contrast agent exposures and physical and cognitive disability in multiple sclerosis
por: Nakamura, Kunio, et al.
Publicado: (2022)

Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting
por: Baldassari, Laura E, et al.
Publicado: (2019)

Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies
por: Feng, Jenny J, et al.
Publicado: (2017)

Intravenous Infusion of Autoserum-Expanded Autologous Mesenchymal Stem Cells in Patients With Chronic Brain Injury: Protocol for a Phase 2 Trial
por: Oka, Shinichi, et al.
Publicado: (2022)

Diagnosis and Management of Progressive Multiple Sclerosis
por: Macaron, Gabrielle, et al.
Publicado: (2019)

Thalamic Injury and Cognition in Multiple Sclerosis
por: Amin, Moein, et al.
Publicado: (2021)

Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in utero
por: Smith, Andrew L, et al.
Publicado: (2019)

The challenges and opportunities of multiple sclerosis care in Latin America
por: Ontaneda, Daniel, et al.
Publicado: (2017)

Management of acute exacerbations in multiple sclerosis
por: Ontaneda, Daniel, et al.
Publicado: (2009)

Decentralised clinical trials in multiple sclerosis research
por: Garjani, Afagh, et al.
Publicado: (2022)

Culture-Expanded Autologous Adipose-Derived Mesenchymal Stem Cell Treatment for Osteonecrosis of the Femoral Head
por: Yoon, Pil Whan, et al.
Publicado: (2021)

Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
por: Stenger, Elizabeth, et al.
Publicado: (2022)

Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
por: Rozier, Pauline, et al.
Publicado: (2018)

Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis
por: Zhou, Yang, et al.
Publicado: (2019)

Safety of Intravenous Autologous Bone Marrow-Derived Mesenchymal Cell Transplantation in 5 Patients With Reduced Left Ventricular Ejection Fraction
por: Sato, Yukihito, et al.
Publicado: (2021)

Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells
por: Ra, Jeong Chan, et al.
Publicado: (2011)

Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial
por: Nabavi, Seyed Massood, et al.
Publicado: (2019)

Implantation of Autologous Expanded Mesenchymal Stromal Cells in Hip Osteonecrosis through Percutaneous Forage: Evaluation of the Operative Technique
por: Gómez-Barrena, Enrique, et al.
Publicado: (2021)

Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis
por: Llufriu, Sara, et al.
Publicado: (2014)

An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2
por: Bakshi, Rohit, et al.
Publicado: (2014)

“Ketofol” a novel balanced intravenous anesthesia for multiple sclerosis patients posted for MRI
por: Bal, Amresh C., et al.
Publicado: (2022)

Volume and location of bone regeneration after autologous expanded mesenchymal stromal cells in hip osteonecrosis: a pilot study
por: Gómez-Barrena, Enrique, et al.
Publicado: (2022)

New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
por: Toljan, Karlo, et al.
Publicado: (2022)

P1260: BIODISTRIBUTION OF LABELED AUTOLOGOUS AND ALLOGENEIC BONE MARROW MESENCHYMAL STROMAL CELLS IN RABBITS AFTER INTRAVENOUS ADMINISTRATION
por: Pestrikova, Anastasiya, et al.
Publicado: (2023)

Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis
por: Planchon, Sarah M, et al.
Publicado: (2018)

Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis
por: Mey, Gabrielle M., et al.
Publicado: (2022)

Ex vivo MRI cell tracking of autologous mesenchymal stromal cells in an ovine osteochondral defect model
por: Markides, Hareklea, et al.
Publicado: (2019)

Predictors of fracture healing in patients with recalcitrant nonunions treated with autologous culture expanded bone marrow‐derived mesenchymal stromal cells
por: Bhattacharjee, Atanu, et al.
Publicado: (2019)

Tissue Expander Capsule for Abdominal Wall in Autologous Breast Reconstruction
por: Webster, Ronaldo Scholze, et al.
Publicado: (2014)

Correction to: Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis
por: Mey, Gabrielle M., et al.
Publicado: (2022)

Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report
por: Vij, Ridhima, et al.
Publicado: (2023)

Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program
por: Vij, Ridhima, et al.
Publicado: (2023)

Re‐evaluating expanding intravenous catheters in medical practice
por: Vazquez, Rigoberto, et al.
Publicado: (2021)

The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory Study
por: Crescenzo, Francesco, et al.
Publicado: (2021)

Exploratory Radiomic Analysis of Conventional vs. Quantitative Brain MRI: Toward Automatic Diagnosis of Early Multiple Sclerosis
por: Lavrova, Elizaveta, et al.
Publicado: (2021)

Mesenchymal properties of SJL mice-stem cells and their efficacy as autologous therapy in a relapsing–remitting multiple sclerosis model
por: Marin-Bañasco, Carmen, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v7qm02dd1k1jfsjir3qb2bu0sa